Literature DB >> 31683461

ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway.

Xudong Tian1,2, Yadong Wang2, Shuhai Li1, Weiming Yue1, Hui Tian1.   

Abstract

OBJECTIVE: To investigate the effect of ZHX2 on lung cancer cells proliferation and apoptosis.
MATERIALS AND METHODS: The mRNA and protein expression of ZHX2 were detected by qRT-PCR and western blot, respectively. The human lung cancer cells were divided into Control, NC, ZHX2, SB, and ZHX2 + Ani groups. The cell proliferation was detected by CCK-8 assay and the cell migration and invasion were detected by Transwell assay. Cell apoptosis was detected by flow cytometry. Apoptosis and p38MAPK signaling pathway related proteins were detected by western blot. The nude mice model of lung cancer xenograft was constructed. The tumor volume and tumor weight were measured. The expression of PCNA protein in tumor tissues was detected by immunohistochemistry. The apoptosis of tumor cells was detected by TUNEL staining. The ZHX2 and p38MAPK signaling pathway related proteins in tumor tissues were detected by western blot.
RESULTS: The expression of ZHX2 gene and protein in the cancer cell lines were significantly decreased. Compared with control and NC groups, the cells proliferation, migration and invasion were inhibited in ZHX2 and SB groups, while the apoptosis and apoptosis related proteins were increased (p< 0.05). Meanwhile, compared with ZHX2 group, the tumor growth rate, volume, weight, the percentage of PCNA-positive cells, and p-P38 MAPK/P38 MAPK were increased significantly in ZHX2 + Ani group, while the apoptotic index and the expression of MMP-9 protein were significantly decreased (p< 0.05).
CONCLUSION: ZHX2 could inhibit proliferation and promote apoptosis of lung cancer cells by inhibiting p38MAPK signaling pathway.

Entities:  

Keywords:  Lung cancer; Zinc-fingers and homeoboxes 2; apoptosis; migration; proliferation

Mesh:

Substances:

Year:  2020        PMID: 31683461     DOI: 10.3233/CBM-190514

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  6 in total

1.  Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.

Authors:  Anqi Cheng; Xiong Guo; Xinglong Dai; Ziwei Wang
Journal:  FEBS Open Bio       Date:  2021-05-24       Impact factor: 2.693

2.  Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway.

Authors:  Yirong Wang; Lei Yang; Yan Yang; Yulin Li
Journal:  Cancer Manag Res       Date:  2021-01-07       Impact factor: 3.989

3.  ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14.

Authors:  Yankun Zhang; Min Sun; Lifen Gao; Xiaohong Liang; Chunhong Ma; Jinghui Lu; Xuetian Yue
Journal:  Cancer Cell Int       Date:  2022-02-12       Impact factor: 5.722

Review 4.  Zinc Fingers and Homeobox Family in Cancer: A Double-Edged Sword.

Authors:  Yonghua Bao; Haifeng Zhang; Zhixue Han; Yongchen Guo; Wancai Yang
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

5.  STAT3 but Not STAT5 Contributes to the Protective Effect of Electroacupuncture Against Myocardial Ischemia/Reperfusion Injury in Mice.

Authors:  Hui-Hui Guo; Xin-Yue Jing; Hui Chen; Hou-Xi Xu; Bing-Mei Zhu
Journal:  Front Med (Lausanne)       Date:  2021-07-09

6.  ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.

Authors:  Jifeng Jiang; Yifeng Sun; Jiadai Xu; Tianhong Xu; Zhao Xu; Peng Liu
Journal:  Cancer Med       Date:  2020-08-11       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.